Klotho Neurosciences, Inc. (KLTO) — Capital Reinvestment Ratio

Latest as of June 2023: 0.00x

Klotho Neurosciences, Inc. (KLTO) has a Capital Reinvestment Ratio of 0.00x as of June 2023, meaning it reinvests 0% of its operating cash flow ($107.55K) in capital expenditures ($2.00). See Klotho Neurosciences, Inc. (KLTO) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$107.55K
USD

Capital Expenditures

$2.00
USD

Data as of

Jun 2023
Most recent filing

Annual Capital Reinvestment Ratio for Klotho Neurosciences, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Klotho Neurosciences, Inc. from None to None. For live market cap and broader valuation context, see KLTO stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow